Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Anastos

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
The Journal of Infectious Diseases|September 30, 2000
The relationship between virus load response to highly active antiretroviral therapy and change in CD4 cell counts: A report from the Women's interagency HIV studyJ A DeHovitz, A Kovacs, J G Feldman, et al.
Annals of Internal Medicine|August 15, 1991
Hypertension in women: what is really known? The Women's Caucus, Working Group on Women's Health of the Society of General Internal MedicineK Anastos, P Charney, R A Charon, et al.
American Journal of Epidemiology|March 7, 2007
Effect of tuberculosis on the survival of women infected with human immunodeficiency virusH López-Gatell, S R Cole, N A Hessol, et al.
Journal of Epidemiology and Community Health|January 29, 2002
Effectiveness of highly active antiretroviral therapy among HIV-1 infected womenS J Gange, Y Barrón, R M Greenblatt, et al.
AIDS (London, England)|October 31, 2001
Discontinuation of potent antiretroviral therapy: predictive value of and impact on CD4 cell counts and HIV RNA levelsL Ahdieh Grant, M J Silverberg, H Palacio, et al.
The Pharmacogenomics Journal|May 3, 2017
Evaluating the association of single-nucleotide polymorphisms with tenofovir exposure in a diverse prospective cohort of women living with HIVS M Baxi, R M Greenblatt, P Bacchetti, et al.
The Journal of Clinical Investigation|February 22, 2001
Preferential suppression of CXCR4-specific strains of HIV-1 by antiviral therapyS Philpott, B Weiser, K Anastos, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 22, 1998
Seroprevalence of HTLV-I and HTLV-II among a cohort of HIV-infected women and women at risk for HIV infection. Women's Interagency HIV StudyE E Telzak, R Hershow, L A Kalish, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2001
Prevalence and correlates of anemia in a large cohort of HIV-infected women: Women's Interagency HIV StudyA M Levine, K Berhane, L Masri-Lavine, et al.
AIDS (London, England)|October 6, 1999
The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women's interagency HIV studyK Anastos, L A Kalish, N Hessol, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
The Journal of Infectious Diseases|September 30, 2000
The relationship between virus load response to highly active antiretroviral therapy and change in CD4 cell counts: A report from the Women's interagency HIV studyJ A DeHovitz, A Kovacs, J G Feldman, et al.
Annals of Internal Medicine|August 15, 1991
Hypertension in women: what is really known? The Women's Caucus, Working Group on Women's Health of the Society of General Internal MedicineK Anastos, P Charney, R A Charon, et al.
American Journal of Epidemiology|March 7, 2007
Effect of tuberculosis on the survival of women infected with human immunodeficiency virusH López-Gatell, S R Cole, N A Hessol, et al.
Journal of Epidemiology and Community Health|January 29, 2002
Effectiveness of highly active antiretroviral therapy among HIV-1 infected womenS J Gange, Y Barrón, R M Greenblatt, et al.
AIDS (London, England)|October 31, 2001
Discontinuation of potent antiretroviral therapy: predictive value of and impact on CD4 cell counts and HIV RNA levelsL Ahdieh Grant, M J Silverberg, H Palacio, et al.
The Pharmacogenomics Journal|May 3, 2017
Evaluating the association of single-nucleotide polymorphisms with tenofovir exposure in a diverse prospective cohort of women living with HIVS M Baxi, R M Greenblatt, P Bacchetti, et al.
The Journal of Clinical Investigation|February 22, 2001
Preferential suppression of CXCR4-specific strains of HIV-1 by antiviral therapyS Philpott, B Weiser, K Anastos, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 22, 1998
Seroprevalence of HTLV-I and HTLV-II among a cohort of HIV-infected women and women at risk for HIV infection. Women's Interagency HIV StudyE E Telzak, R Hershow, L A Kalish, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2001
Prevalence and correlates of anemia in a large cohort of HIV-infected women: Women's Interagency HIV StudyA M Levine, K Berhane, L Masri-Lavine, et al.
AIDS (London, England)|October 6, 1999
The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women's interagency HIV studyK Anastos, L A Kalish, N Hessol, et al.
Pageof 5